Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in J Neurosci

Retrieve available abstracts of 65 articles:
HTML format
Text format



Single Articles


    July 2018
  1. CHANDRA S, Jana M, Pahan K
    Aspirin induces Lysosomal biogenesis and attenuates Amyloid plaque pathology in a mouse model of Alzheimer's disease via PPARalpha.
    J Neurosci. 2018 Jul 2. pii: JNEUROSCI.0054-18.2018.
    PubMed     Text format     Abstract available


  2. WU L, Zhang X, Zhao L
    Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimer's Disease Risk Reduction and Early Intervention.
    J Neurosci. 2018 Jul 2. pii: JNEUROSCI.2262-17.2018.
    PubMed     Text format     Abstract available


    June 2018
  3. SANJARI MOGHADDAM H, Aarabi MH
    Abeta-Mediated Dysregulation of F-Actin Nanoarchitecture Leads to Loss of Dendritic Spines and Alzheimer's Disease-Related Cognitive Impairments.
    J Neurosci. 2018;38:5840-5842.
    PubMed     Text format    


    March 2018
  4. RAJENDRAN L, Paolicelli RC
    Microglia-Mediated Synapse Loss in Alzheimer's Disease.
    J Neurosci. 2018;38:2911-2919.
    PubMed     Text format     Abstract available


  5. VANDERHEYDEN WM, Lim MM, Musiek ES, Gerstner JR, et al
    Alzheimer's Disease and Sleep-Wake Disturbances: Amyloid, Astrocytes, and Animal Models.
    J Neurosci. 2018;38:2901-2910.
    PubMed     Text format     Abstract available


    February 2018
  6. LIMA-FILHO RAS, Oliveira MM
    A Role for Cellular Prion Protein in Late-Onset Alzheimer's Disease: Evidence from Preclinical Studies.
    J Neurosci. 2018;38:2146-2148.
    PubMed     Text format    


    January 2018
  7. MUELLER MC, Baranowski BJ, Hayward GC
    New Insights on the Role of Residue 673 of APP in Alzheimer's Disease.
    J Neurosci. 2018;38:515-517.
    PubMed     Text format    


    December 2017
  8. PEERA KOMMADDI R, Das D, Karunakaran S, Nanguneri S, et al
    Abeta mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease.
    J Neurosci. 2017 Dec 15. pii: JNEUROSCI.2127-17.2017.
    PubMed     Text format     Abstract available


  9. WANG Z, Jackson RJ, Hong W, Taylor WM, et al
    Human Brain-Derived Abeta Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
    J Neurosci. 2017;37:11947-11966.
    PubMed     Text format     Abstract available


    November 2017
  10. VAN DIJKEN I, van der Vlag M, Flores Hernandez R, Ross A, et al
    Perspectives on Treatment of Alzheimer's Disease: A Closer Look into EphB2 Depletion.
    J Neurosci. 2017;37:11296-11297.
    PubMed     Text format    


  11. RAY A, Speese SD, Logan MA
    Glial Draper rescues Abeta toxicity in a Drosophila model of Alzheimer's Disease.
    J Neurosci. 2017 Nov 6. pii: 0862-17. doi: 10.1523/JNEUROSCI.0862-17.2017.
    PubMed     Text format     Abstract available


  12. PARENT MJ, Zimmer ER, Shin M, Kang MS, et al
    Multimodal imaging in rat model recapitulates Alzheimer's Disease biomarkers abnormalities.
    J Neurosci. 2017 Nov 2. pii: 1346-17. doi: 10.1523/JNEUROSCI.1346-17.2017.
    PubMed     Text format     Abstract available


    October 2017
  13. NAKAZATO R, Kawabe K, Yamada D, Ikeno S, et al
    Disruption of Bmal1 Impairs Blood-Brain Barrier Integrity via Pericyte Dysfunction.
    J Neurosci. 2017;37:10052-10062.
    PubMed     Text format     Abstract available


  14. BANKS RA, Gibbons GS, Kim B, Xu H, et al
    GFP-mutant human tau transgenic mice develop tauopathy following CNS injections of Alzheimer's brain-derived pathological tau or synthetic mutant human tau fibrils.
    J Neurosci. 2017 Oct 6. pii: 2393-17. doi: 10.1523/JNEUROSCI.2393-17.2017.
    PubMed     Text format     Abstract available


    August 2017
  15. SUSS P
    Remote Control: Impacts of Peripheral Tumor Necrosis Factor-Alpha on Alzheimer Disease-Related Pathology.
    J Neurosci. 2017;37:8045-8047.
    PubMed     Text format    


  16. SALAZAR SV, Gallardo C, Kaufman AC, Herber CS, et al
    Conditional Deletion of Prnp Rescues Behavioral and Synaptic Deficits after Disease Onset in Transgenic Alzheimer's Disease.
    J Neurosci. 2017 Aug 21. pii: 0722-17. doi: 10.1523/JNEUROSCI.0722-17.2017.
    PubMed     Text format     Abstract available


  17. LI Y, Chen Z, Gao Y, Pan G, et al
    Synaptic adhesion molecule Pcdh-gammaC5 mediates synaptic dysfunction in Alzheimer's disease.
    J Neurosci. 2017 Aug 21. pii: 1051-17. doi: 10.1523/JNEUROSCI.1051-17.2017.
    PubMed     Text format     Abstract available


  18. CAPRELLI MT
    Regulation of Synaptic Amyloid-beta Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    J Neurosci. 2017;37:7291-7293.
    PubMed     Text format    


    June 2017
  19. SOMPOL P, Furman JL, Pleiss MM, Kraner SD, et al
    Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Abeta-Bearing Mice.
    J Neurosci. 2017;37:6132-6148.
    PubMed     Text format     Abstract available


  20. ZHANG S, Wang Z, Cai F, Zhang M, et al
    BACE1 cleavage site selection critical for amyloidogenesis and Alzheimer's pathogenesis.
    J Neurosci. 2017 Jun 16. pii: 0340-17. doi: 10.1523/JNEUROSCI.0340-17.2017.
    PubMed     Text format     Abstract available


  21. DINIZ LP, Tortelli V, Matias I, Morgado J, et al
    Astrocyte transforming growth factor beta 1 protects synapses against Abeta oligomers in Alzheimer's disease model.
    J Neurosci. 2017 Jun 12. pii: 3351-16. doi: 10.1523/JNEUROSCI.3351-16.2017.
    PubMed     Text format     Abstract available


    May 2017
  22. PAOURI E, Tzara O, Kartalou GI, Zenelak S, et al
    Peripheral Tumor Necrosis Factor-Alpha (TNF-alpha) Modulates Amyloid Pathology by Regulating Blood-Derived Immune Cells and Glial Response in the Brain of AD/TNF Transgenic Mice.
    J Neurosci. 2017;37:5155-5171.
    PubMed     Text format     Abstract available


  23. SELLES MC, Fortuna JTS, Santos LE
    Immunomodulation via Toll-like Receptor 9: An Adjunct Therapy Strategy against Alzheimer's Disease?
    J Neurosci. 2017;37:4864-4867.
    PubMed     Text format    


  24. ROYEA J, Zhang L, Tong XK, Hamel E, et al
    Angiotensin IV receptors mediate the cognitive and cerebrovascular benefits of losartan in a mouse model of Alzheimer's disease.
    J Neurosci. 2017 May 5. pii: 0329-17. doi: 10.1523/JNEUROSCI.0329-17.2017.
    PubMed     Text format     Abstract available


    April 2017
  25. GAMAGE KK, Kumar S
    Aducanumab Therapy Ameliorates Calcium Overload in a Mouse Model of Alzheimer's Disease.
    J Neurosci. 2017;37:4430-4432.
    PubMed     Text format    


  26. BAEK SH, Park SJ, In Jeong J, Hyun Kim S, et al
    Inhibition of Drp1 Ameliorates Synaptic Depression, Abeta Deposition and Cognitive Impairment in Alzheimer's Disease Model.
    J Neurosci. 2017 Apr 21. pii: 2385-16. doi: 10.1523/JNEUROSCI.2385-16.2017.
    PubMed     Text format     Abstract available


    March 2017
  27. GRATTON C, Yousef S, Aarts E, Wallace DL, et al
    Cholinergic, but not dopaminergic or noradrenergic, enhancement sharpens visual spatial perception in humans.
    J Neurosci. 2017 Mar 23. pii: 2405-16. doi: 10.1523/JNEUROSCI.2405-16.2017.
    PubMed     Text format     Abstract available


    February 2017
  28. YE X, Feng T, Tammineni P, Chang Q, et al
    Regulation of Synaptic Abeta Generation Through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    J Neurosci. 2017 Feb 3. pii: 2851-16. doi: 10.1523/JNEUROSCI.2851-16.2017.
    PubMed     Text format     Abstract available


    January 2017
  29. ZHANG ZH, Wu QY, Zheng R, Chen C, et al
    Selenomethionine mitigates cognitive decline by targeting both tau hyperphosphorylation and autophagic clearance in an Alzheimer's disease mouse model.
    J Neurosci. 2017 Jan 30. pii: 3229-16. doi: 10.1523/JNEUROSCI.3229-16.2017.
    PubMed     Text format     Abstract available


  30. JAY TR, Hirsch AM, Broihier ML, Miller CM, et al
    Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease.
    J Neurosci. 2017;37:637-647.
    PubMed     Text format     Abstract available


  31. VIEIRA MN, Beckman D
    Training Microglia to Resist Alzheimer's Disease.
    J Neurosci. 2017;37:477-479.
    PubMed     Text format    


  32. DATTA D
    APP Modulates Abeta-Induced Activation of Microglia in Mouse Model of Alzheimer's Disease.
    J Neurosci. 2017;37:238-240.
    PubMed     Text format    


  33. YANG T, Li S, Xu H, Walsh DM, et al
    Large Soluble Oligomers of Amyloid beta-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.
    J Neurosci. 2017;37:152-163.
    PubMed     Text format     Abstract available


    December 2016
  34. PRIETO GA, Trieu BH, Dang CT, Bilousova T, et al
    Pharmacological rescue of long-term potentiation in Alzheimer diseased synapses.
    J Neurosci. 2016 Dec 16. pii: 2774.
    PubMed     Text format     Abstract available


  35. JAY TR, Hirsch AM, Broihier ML, Miller CM, et al
    Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer's disease.
    J Neurosci. 2016 Dec 9. pii: 2110.
    PubMed     Text format     Abstract available


    November 2016
  36. LEDO JH, Azevedo EP, Beckman D, Ribeiro FC, et al
    Cross Talk Between Brain Innate Immunity and Serotonin Signaling Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid-beta Oligomers in Mice.
    J Neurosci. 2016;36:12106-12116.
    PubMed     Text format     Abstract available


  37. SHI XD, Sun K, Hu R, Liu XY, et al
    Blocking the Interaction between EphB2 and ADDLs by a Small Peptide Rescues Impaired Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer's Disease.
    J Neurosci. 2016;36:11959-11973.
    PubMed     Text format     Abstract available


  38. ZHANG H, Sun S, Wu L, Pchitskaya E, et al
    Store-Operated Calcium Channel Complex in Postsynaptic Spines: A New Therapeutic Target for Alzheimer's Disease Treatment.
    J Neurosci. 2016;36:11837-11850.
    PubMed     Text format     Abstract available


    October 2016
  39. SHU S, Zhu H, Tang N, Chen W, et al
    Selective Degeneration of Entorhinal-CA1 Synapses in Alzheimer's Disease via Activation of DAPK1.
    J Neurosci. 2016;36:10843-10852.
    PubMed     Text format     Abstract available


    September 2016
  40. SAITO T, Matsuba Y, Yamazaki N, Hashimoto S, et al
    Calpain Activation in Alzheimer's Model Mice Is an Artifact of APP and Presenilin Overexpression.
    J Neurosci. 2016;36:9933-6.
    PubMed     Text format     Abstract available


    August 2016
  41. DINKINS MB, Enasko J, Hernandez C, Wang G, et al
    Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
    J Neurosci. 2016;36:8653-67.
    PubMed     Text format     Abstract available


  42. MANOCHA GD, Floden AM, Rausch K, Kulas JA, et al
    APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease.
    J Neurosci. 2016;36:8471-86.
    PubMed     Text format     Abstract available


    July 2016
  43. SPENCER B, Desplats PA, Overk CR, Valera-Martin E, et al
    Reducing Endogenous alpha-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model.
    J Neurosci. 2016;36:7971-84.
    PubMed     Text format     Abstract available


    March 2016
  44. SAKAE N, Liu CC, Shinohara M, Frisch-Daiello J, et al
    ABCA7 Deficiency Accelerates Amyloid-beta Generation and Alzheimer's Neuronal Pathology.
    J Neurosci. 2016;36:3848-59.
    PubMed     Text format     Abstract available


  45. JAOUEN F, Gascon E
    Understanding the Role of miR-33 in Brain Lipid Metabolism: Implications for Alzheimer's Disease.
    J Neurosci. 2016;36:2558-60.
    PubMed     Text format    


    January 2016
  46. OLIVEIRA MM, Lourenco MV
    Integrated Stress Response: Connecting ApoE4 to Memory Impairment in Alzheimer's Disease.
    J Neurosci. 2016;36:1053-5.
    PubMed     Text format    


  47. MEIER S, Bell M, Lyons DN, Rodriguez-Rivera J, et al
    Pathological Tau Promotes Neuronal Damage by Impairing Ribosomal Function and Decreasing Protein Synthesis.
    J Neurosci. 2016;36:1001-7.
    PubMed     Text format     Abstract available


  48. LIAN H, Litvinchuk A, Chiang AC, Aithmitti N, et al
    Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
    J Neurosci. 2016;36:577-89.
    PubMed     Text format     Abstract available


  49. YUAN P, Grutzendler J
    Attenuation of beta-Amyloid Deposition and Neurotoxicity by Chemogenetic Modulation of Neural Activity.
    J Neurosci. 2016;36:632-41.
    PubMed     Text format     Abstract available


    December 2015
  50. FERRIER J, Bayet-Robert M, Dalmann R, El Guerrab A, et al
    Cholinergic Neurotransmission in the Posterior Insular Cortex Is Altered in Preclinical Models of Neuropathic Pain: Key Role of Muscarinic M2 Receptors in Donepezil-Induced Antinociception.
    J Neurosci. 2015;35:16418-16430.
    PubMed     Text format     Abstract available


    November 2015
  51. LIU B, Le KX, Park MA, Wang S, et al
    In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice.
    J Neurosci. 2015;35:15716-30.
    PubMed     Text format     Abstract available


  52. RAPPAPORT AN, Jacob E, Sharma V, Inberg S, et al
    Expression of Quinone Reductase-2 in the Cortex Is a Muscarinic Acetylcholine Receptor-Dependent Memory Consolidation Constraint.
    J Neurosci. 2015;35:15568-81.
    PubMed     Text format     Abstract available


  53. OSTAPCHENKO VG, Chen M, Guzman MS, Xie YF, et al
    The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to beta-Amyloid Oligomer-Related Neurotoxicity and Memory Impairment.
    J Neurosci. 2015;35:15157-69.
    PubMed     Text format     Abstract available


    October 2015
  54. CACCAMO A, Branca C, Talboom JS, Shaw DM, et al
    Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.
    J Neurosci. 2015;35:14042-56.
    PubMed     Text format     Abstract available


    September 2015
  55. ZHANG H, Wu L, Pchitskaya E, Zakharova O, et al
    Neuronal Store-Operated Calcium Entry and Mushroom Spine Loss in Amyloid Precursor Protein Knock-In Mouse Model of Alzheimer's Disease.
    J Neurosci. 2015;35:13275-86.
    PubMed     Text format     Abstract available


  56. SEGEV Y, Barrera I, Ounallah-Saad H, Wibrand K, et al
    PKR Inhibition Rescues Memory Deficit and ATF4 Overexpression in ApoE epsilon4 Human Replacement Mice.
    J Neurosci. 2015;35:12986-93.
    PubMed     Text format     Abstract available


  57. PROULX E, Fraser P, McLaurin J, Lambe EK, et al
    Impaired Cholinergic Excitation of Prefrontal Attention Circuitry in the TgCRND8 Model of Alzheimer's Disease.
    J Neurosci. 2015;35:12779-91.
    PubMed     Text format     Abstract available


  58. GILLEBERT CR, Schaeverbeke J, Bastin C, Neyens V, et al
    3D Shape Perception in Posterior Cortical Atrophy: A Visual Neuroscience Perspective.
    J Neurosci. 2015;35:12673-92.
    PubMed     Text format     Abstract available


    August 2015
  59. GONTIER G, George C, Chaker Z, Holzenberger M, et al
    Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-beta Clearance.
    J Neurosci. 2015;35:11500-13.
    PubMed     Text format     Abstract available


  60. SHAW JL, Zhang S, Chang KT
    Bidirectional Regulation of Amyloid Precursor Protein-Induced Memory Defects by Nebula/DSCR1: A Protein Upregulated in Alzheimer's Disease and Down Syndrome.
    J Neurosci. 2015;35:11374-83.
    PubMed     Text format     Abstract available


  61. MEGILL A, Tran T, Eldred K, Lee NJ, et al
    Defective Age-Dependent Metaplasticity in a Mouse Model of Alzheimer's Disease.
    J Neurosci. 2015;35:11346-57.
    PubMed     Text format     Abstract available


    July 2015
  62. BESSON FL, La Joie R, Doeuvre L, Gaubert M, et al
    Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease.
    J Neurosci. 2015;35:10402-11.
    PubMed     Text format     Abstract available


    June 2015
  63. HARCHA PA, Vargas A, Yi C, Koulakoff AA, et al
    Hemichannels Are Required for Amyloid beta-Peptide-Induced Degranulation and Are Activated in Brain Mast Cells of APPswe/PS1dE9 Mice.
    J Neurosci. 2015;35:9526-38.
    PubMed     Text format     Abstract available


  64. CASALI BT, Corona AW, Mariani MM, Karlo JC, et al
    Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer's Disease.
    J Neurosci. 2015;35:9173-81.
    PubMed     Text format     Abstract available


    May 2015
  65. SEN A, Nelson TJ, Alkon DL
    ApoE4 and Abeta Oligomers Reduce BDNF Expression via HDAC Nuclear Translocation.
    J Neurosci. 2015;35:7538-51.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: